Indoco Remedies Declares Unaudited Q1 FY27 Results

Indoco Remedies Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results along with a Limited Review Report from statutory auditors M/s. Gokhale & Sathe, Chartered Accountants, who issued an unmodified opinion. The company reported an exceptional item gain of ₹9,734 Lakhs from the slump sale of its Ophthalmic Business Division to Sunways (India) Private Limited. The Board meeting commenced at 10:45 a.m. and concluded at 11:45 a.m. on July 28, 2026.